<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36750564</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>07</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Multi-ancestry and multi-trait genome-wide association meta-analyses inform clinical risk prediction for systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>668</StartPage><MedlinePgn>668</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">668</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-36306-5</ELocationID><Abstract><AbstractText>Systemic lupus erythematosus is a heritable autoimmune disease that predominantly affects young women. To improve our understanding of genetic etiology, we conduct multi-ancestry and multi-trait meta-analysis of genome-wide association studies, encompassing 12 systemic lupus erythematosus cohorts from 3 different ancestries and 10 genetically correlated autoimmune diseases, and identify 16 novel loci. We also perform transcriptome-wide association studies, computational drug repurposing analysis, and cell type enrichment analysis. We discover putative drug classes, including a histone deacetylase inhibitor that could be repurposed to treat lupus. We also identify multiple cell types enriched with putative target genes, such as non-classical monocytes and B cells, which may be targeted for future therapeutics. Using this newly assembled result, we further construct polygenic risk score models and demonstrate that integrating polygenic risk score with clinical lab biomarkers improves the diagnostic accuracy of systemic lupus erythematosus using the Vanderbilt BioVU and Michigan Genomics Initiative&#xa0;biobanks.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khunsriraksakul</LastName><ForeName>Chachrit</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5131-1229</Identifier><AffiliationInfo><Affiliation>Program in Bioinformatics and Genomics, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Personalized Medicine, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qinmengge</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markus</LastName><ForeName>Havell</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Program in Bioinformatics and Genomics, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Personalized Medicine, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrick</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauteraud</LastName><ForeName>Renan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGuire</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xingyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2727-7240</Identifier><AffiliationInfo><Affiliation>Program in Bioinformatics and Genomics, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lida</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-7990-7347</Identifier><AffiliationInfo><Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenoy</LastName><ForeName>Ganesh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bingshan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2129-168X</Identifier><AffiliationInfo><Affiliation>Department of Molecular Physiology &amp; Biophysics, Vanderbilt University, Nashville, TN, 37235, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Nancy J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrel</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoi</LastName><ForeName>Lam C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Bibo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dajiang J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0001-6553-858X</Identifier><AffiliationInfo><Affiliation>Program in Bioinformatics and Genomics, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. dajiang.liu@psu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Personalized Medicine, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. dajiang.liu@psu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, 17033, USA. dajiang.liu@psu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RC2 GM092618</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG004798</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 OD032630</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 HG011035</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD074711</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AR071077</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD017985</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 LM012415</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG011035</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 HL065962</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM126479</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM115305</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG008983</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS032830</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 HG012358</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG006378</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI160138</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM118294</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 RR025141</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36750564</ArticleId><ArticleId IdType="pmc">PMC9905560</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-36306-5</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-36306-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dall&#x2019;Era M, et al. The incidence and prevalence of systemic lupus erythematosus in san francisco county, california: the california lupus surveillance project. Arthritis Rheumatol. 2017;69:1996&#x2013;2005.</Citation><ArticleIdList><ArticleId IdType="pubmed">28891237</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly PM, et al. The incidence and prevalence of systemic lupus erythematosus in new york county (manhattan), New York: the manhattan lupus surveillance program. Arthritis Rheumatol. 2017;69:2006&#x2013;2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28891252</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr. Opin. Rheumatol. 2018;30:144&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6026543</ArticleId><ArticleId IdType="pubmed">29251660</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugger L, Jensen LT, Rossjohn J. Challenges, progress, and prospects of developing therapies to treat autoimmune diseases. Cell. 2020;181:63&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243797</ArticleId></ArticleIdList></Reference><Reference><Citation>Felten R, et al. 10 most important contemporary challenges in the management of SLE. Lupus Sci. Med. 2019;6:e000303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6340557</ArticleId><ArticleId IdType="pubmed">30729019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernder A, et al. Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort. Lupus. 2021;30:431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933718</ArticleId><ArticleId IdType="pubmed">33402036</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter EE, Barr SG, Clarke AE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat. Rev. Rheumatol. 2016;12:605&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pubmed">27558659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam V, et al. Benefits and limitations of genome-wide association studies. Nat. Rev. Genet. 2019;20:467&#x2013;484.</Citation><ArticleIdList><ArticleId IdType="pubmed">31068683</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Gamez E, Trynka G. From GWAS to function: using functional genomics to identify the mechanisms underlying complex diseases. Front Genet. 2020;11:424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237642</ArticleId><ArticleId IdType="pubmed">32477401</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 2010;6:683&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3135416</ArticleId><ArticleId IdType="pubmed">21060334</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, et al. Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat. Commun. 2021;12:772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Morris DL, Vyse TJ. Genetic advances in systemic lupus erythematosus: an update. Curr. Opin. Rheumatol. 2017;29:423&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">28509669</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen L, et al. Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese population. Ann. Rheum. Dis. 2018;77:417.</Citation><ArticleIdList><ArticleId IdType="pubmed">29233832</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, et al. Identification of ST3AGL4, MFHAS1, CSNK2A2 and CD226 as loci associated with systemic lupus erythematosus (SLE) and evaluation of SLE genetics in drug repositioning. Ann. Rheum. Dis. 2018;77:1078&#x2013;1084.</Citation><ArticleIdList><ArticleId IdType="pubmed">29625966</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez RK, et al. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science. 2022;376:eabf1970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297655</ArticleId><ArticleId IdType="pubmed">35389781</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 2015;47:1457&#x2013;1464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 2017;8:16021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 2008;40:204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712260</ArticleId><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hom G, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med. 2008;358:900&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204098</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Q, et al. Genome-wide association study on Northern Chinese identifies KLF2, DOT1L and STAB2 associated with systemic lupus erythematosus. Rheumatol. (Oxf.) 2021;60:4407&#x2013;4417.</Citation><ArticleIdList><ArticleId IdType="pubmed">33493351</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangtanatakul P, et al. Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population. Arthritis Res Ther. 2020;22:185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414652</ArticleId><ArticleId IdType="pubmed">32771030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaue S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat. Genet. 2021;53:1415&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pubmed">34594039</ArticleId></ArticleIdList></Reference><Reference><Citation>Alarc&#xf3;n-Riquelme ME, et al. Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture. Arthritis Rheumatol. 2016;68:932&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4829354</ArticleId><ArticleId IdType="pubmed">26606652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawistowski, M. et al. The Michigan Genomics Initiative: A biobank linking genotypes and electronic clinical records in Michigan Medicine patients. Cell Genomics10.1016/j.xgen.2023.100257 (2023).</Citation></Reference><Reference><Citation>Richard-Miceli C, Criswell LA. Emerging patterns of genetic overlap across autoimmune disorders. Genome Med. 2012;4:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3334554</ArticleId><ArticleId IdType="pubmed">22284131</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 2009;10:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">19092835</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S, Chengappa K, Negi V. Systemic lupus erythematosus and overlap: A clinician perspective. Clin. Dermatol. Rev. 2019;3:12&#x2013;17.</Citation></Reference><Reference><Citation>Bulik-Sullivan BK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 2015;47:291&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan B, et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 2015;47:1236&#x2013;1241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4797329</ArticleId><ArticleId IdType="pubmed">26414676</ArticleId></ArticleIdList></Reference><Reference><Citation>Turley P, et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat. Genet. 2018;50:229&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805593</ArticleId><ArticleId IdType="pubmed">29292387</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuire D, et al. Model-based assessment of replicability for genome-wide association meta-analysis. Nat. Commun. 2021;12:1964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009871</ArticleId><ArticleId IdType="pubmed">33785739</ArticleId></ArticleIdList></Reference><Reference><Citation>Icen M, et al. Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortality. J. Rheumatol. 2009;36:50&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2836232</ArticleId><ArticleId IdType="pubmed">19004043</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoussaini M, et al. Open targets genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 2021;49:D1311&#x2013;d1320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778936</ArticleId><ArticleId IdType="pubmed">33045747</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin C, et al. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-&#x3ba;B and negatively regulates inflammatory responses. Sci. Rep. 2017;7:46097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5380948</ArticleId><ArticleId IdType="pubmed">28378844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy JM, et al. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation. J. Exp. Med. 2014;211:2519&#x2013;2535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4267237</ArticleId><ArticleId IdType="pubmed">25403443</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves I, et al. AB0123 Changes in cellular glycosylation as a key factor in the immunopathogenesis of systemic lupus erythematosus. Ann. Rheum. Dis. 2020;79:1361&#x2013;1362.</Citation></Reference><Reference><Citation>Pereira MS, et al. Glycans as key checkpoints of T cell activity and function. Front Immunol. 2018;9:2754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6277680</ArticleId><ArticleId IdType="pubmed">30538706</ArticleId></ArticleIdList></Reference><Reference><Citation>Starke C, Steinkasserer A, Voll RE, Zinser E. Soluble human CD83 ameliorates lupus in NZB/W F1 mice. Immunobiology. 2013;218:1411&#x2013;1415.</Citation><ArticleIdList><ArticleId IdType="pubmed">23886695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lappalainen T, et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 2013;501:506&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3918453</ArticleId><ArticleId IdType="pubmed">24037378</ArticleId></ArticleIdList></Reference><Reference><Citation>Battle A, et al. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res. 2014;24:14&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3875855</ArticleId><ArticleId IdType="pubmed">24092820</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunsriraksakul C, et al. Integrating 3D genomic and epigenomic data to enhance target gene discovery and drug repurposing in transcriptome-wide association studies. Nat. Commun. 2022;13:3258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9171100</ArticleId><ArticleId IdType="pubmed">35672318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, F. et al. Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing. Nat. Genet.10.1038/s41588-022-01282-x (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36702996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, et al. Global discovery of lupus genetic risk variant allelic enhancer activity. Nat. Commun. 2021;12:1611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955039</ArticleId><ArticleId IdType="pubmed">33712590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhamidipati K, et al. CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function. Front Immunol. 2020;11:626820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917337</ArticleId><ArticleId IdType="pubmed">33658999</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao YM, et al. Increased circulating interleukin-8 levels in systemic lupus erythematosus patients: a meta-analysis. Biomark. Med. 2018;12:1291&#x2013;1302.</Citation><ArticleIdList><ArticleId IdType="pubmed">30511585</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 2018;18:134&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Gallo LM, et al. Evidence of new risk genetic factor to systemic lupus erythematosus: the UBASH3A gene. PLoS One. 2013;8:e60646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3614928</ArticleId><ArticleId IdType="pubmed">23565265</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen BN, et al. Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young. Clin. Dev. Immunol. 2013;2013:417657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3866813</ArticleId><ArticleId IdType="pubmed">24367383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, et al. High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. Ann. Rheum. Dis. 2015;74:e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467986</ArticleId><ArticleId IdType="pubmed">24532676</ArticleId></ArticleIdList></Reference><Reference><Citation>Plagnol V, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet. 2011;7:e1002216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150451</ArticleId><ArticleId IdType="pubmed">21829393</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Decreased UBASH3A mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Inflammation. 2015;38:1903&#x2013;1910.</Citation><ArticleIdList><ArticleId IdType="pubmed">25876712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee R, et al. Non-Classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous. Sci. Rep. 2015;5:13886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4566081</ArticleId><ArticleId IdType="pubmed">26358827</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, et al. CD16(+) monocyte subset was enriched and functionally exacerbated in driving t-cell activation and b-cell response in systemic lupus erythematosus. Front Immunol. 2016;7:512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5116853</ArticleId><ArticleId IdType="pubmed">27917174</ArticleId></ArticleIdList></Reference><Reference><Citation>Odendahl M, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 2000;165:5970&#x2013;5979.</Citation><ArticleIdList><ArticleId IdType="pubmed">11067960</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharer CD, et al. ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in na&#xef;ve SLE B cells. Sci. Rep. 2016;6:27030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4888756</ArticleId><ArticleId IdType="pubmed">27249108</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Liang S, Zhang C. NK cells in autoimmune diseases: protective or pathogenic? Front Immunol. 2021;12:624687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7994264</ArticleId><ArticleId IdType="pubmed">33777006</ArticleId></ArticleIdList></Reference><Reference><Citation>Arazi A, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat. Immunol. 2019;20:902&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6726437</ArticleId><ArticleId IdType="pubmed">31209404</ArticleId></ArticleIdList></Reference><Reference><Citation>Comte D, et al. Signaling lymphocytic activation molecule family member 7 engagement restores defective effector CD8+ T cell function in systemic lupus erythematosus. Arthritis Rheumatol. 2017;69:1035&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5406259</ArticleId><ArticleId IdType="pubmed">28076903</ArticleId></ArticleIdList></Reference><Reference><Citation>Stohl W. Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus. Arthritis Rheum. 1995;38:506&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">7718004</ArticleId></ArticleIdList></Reference><Reference><Citation>Akahoshi M, et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 1999;42:1644&#x2013;1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">10446863</ArticleId></ArticleIdList></Reference><Reference><Citation>al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J. Clin. Immunol. 1993;13:58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">8445045</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharer CD, et al. Epigenetic programming underpins B cell dysfunction in human SLE. Nat. Immunol. 2019;20:1071&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642679</ArticleId><ArticleId IdType="pubmed">31263277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb J. The connectivity map: a new tool for biomedical research. Nat. Rev. Cancer. 2007;7:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17186018</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. A next generation connectivity map: l1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437&#x2013;1452.e17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990023</ArticleId><ArticleId IdType="pubmed">29195078</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J, et al. Selective histone deacetylase 6 inhibition normalizes b cell activation and germinal center formation in a model of systemic Lupus Erythematosus. Front Immunol. 2019;10:2512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6823248</ArticleId><ArticleId IdType="pubmed">31708928</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi G, et al. mTOR inhibitor INK128 attenuates systemic lupus erythematosus by regulating inflammation-induced CD11b(+)Gr1(+) cells. Biochim Biophys. Acta Mol. Basis Dis. 2019;1865:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">30292636</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai ZW, et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. Lancet. 2018;391:1186&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5891154</ArticleId><ArticleId IdType="pubmed">29551338</ArticleId></ArticleIdList></Reference><Reference><Citation>Frese-Schaper M, Zbaeren J, Gugger M, Monestier M, Frese S. Reversal of established lupus nephritis and prolonged survival of New Zealand black x New Zealand white mice treated with the topoisomerase I inhibitor irinotecan. J. Immunol. 2010;184:2175&#x2013;2182.</Citation><ArticleIdList><ArticleId IdType="pubmed">20083657</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd-Jones LR, et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat. Commun. 2019;10:5086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6841727</ArticleId><ArticleId IdType="pubmed">31704910</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 2011;88:76&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014363</ArticleId><ArticleId IdType="pubmed">21167468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G, Zhao H. A fast and robust Bayesian nonparametric method for prediction of complex traits using summary statistics. PLoS Genet. 2021;17:e1009697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8341714</ArticleId><ArticleId IdType="pubmed">34310601</ArticleId></ArticleIdList></Reference><Reference><Citation>Priv&#xe9;, F., Arbel, J. &amp; Vilhj&#xe1;lmsson, B. J. LDpred2: better, faster, stronger. Bioinformatics36, 5424&#x2013;5431 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8016455</ArticleId><ArticleId IdType="pubmed">33326037</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe1;rquez-Luna, C. et al. Incorporating functional priors improves polygenic prediction accuracy in UK Biobank and 23andMe data sets. Nat. Commun.12, 6052 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8523709</ArticleId><ArticleId IdType="pubmed">34663819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z, et al. PUMAS: fine-tuning polygenic risk scores with GWAS summary statistics. Genome Biol. 2021;22:257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8419981</ArticleId><ArticleId IdType="pubmed">34488838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge T, Chen C-Y, Ni Y, Feng Y-CA, Smoller JW. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 2019;10:1776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6467998</ArticleId><ArticleId IdType="pubmed">30992449</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak TSH, Porsch RM, Choi SW, Zhou X, Sham PC. Polygenic scores via penalized regression on summary statistics. Genet Epidemiol. 2017;41:469&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">28480976</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, et al. Developing electronic health record algorithms that accurately identify patients with systemic lupus erythematosus. Arthritis Care Res. 2017;69:687&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5219863</ArticleId><ArticleId IdType="pubmed">27390187</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, et al. 2019 european league against rheumatism/american college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400&#x2013;1412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye M, et al. Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. J. Am. Coll. Cardiol. 2018;72:1883&#x2013;1893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6176870</ArticleId><ArticleId IdType="pubmed">30309464</ArticleId></ArticleIdList></Reference><Reference><Citation>Mars N, et al. The role of polygenic risk and susceptibility genes in breast cancer over the course of life. Nat. Commun. 2020;11:6383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736877</ArticleId><ArticleId IdType="pubmed">33318493</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan P, et al. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation. 2017;135:2091&#x2013;2101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5484076</ArticleId><ArticleId IdType="pubmed">28223407</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera AV, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 2018;50:1219&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128408</ArticleId><ArticleId IdType="pubmed">30104762</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12:44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236300</ArticleId><ArticleId IdType="pubmed">32423490</ArticleId></ArticleIdList></Reference><Reference><Citation>Drenkard C, Lim SS. Update on lupus epidemiology: advancing health disparities research through the study of minority populations. Curr. Opin. Rheumatol. 2019;31:689&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6791519</ArticleId><ArticleId IdType="pubmed">31436582</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello A, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005&#x2013;D1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen GB, et al. Across-cohort QC analyses of GWAS summary statistics from complex traits. Eur. J. Hum. Genet. 2016;25:137&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5159754</ArticleId><ArticleId IdType="pubmed">27552965</ArticleId></ArticleIdList></Reference><Reference><Citation>Han B, et al. A general framework for meta-analyzing dependent studies with overlapping subjects in association mapping. Hum. Mol. Genet. 2016;25:1857&#x2013;1866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4986332</ArticleId><ArticleId IdType="pubmed">26908615</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x2013;2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. Global Biobank analyses provide lessons for developing polygenic risk scores across diverse cohorts. Cell Genomics3, 100241 (2023).</Citation></Reference><Reference><Citation>Han B, Eskin E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am. J. Hum. Genet. 2011;88:586&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146723</ArticleId><ArticleId IdType="pubmed">21565292</ArticleId></ArticleIdList></Reference><Reference><Citation>The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>The ENOCDE Project Consortium. A user&#x2019;s guide to the encyclopedia of DNA elements (ENCODE) PLoS Biol. 2011;9:e1001046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3079585</ArticleId><ArticleId IdType="pubmed">21526222</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao SS, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159:1665&#x2013;1680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5635824</ArticleId><ArticleId IdType="pubmed">25497547</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. The 3D genome browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 2018;19:151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172833</ArticleId><ArticleId IdType="pubmed">30286773</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung I, et al. A compendium of promoter-centered long-range chromatin interactions in the human genome. Nat. Genet. 2019;51:1442&#x2013;1449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778519</ArticleId><ArticleId IdType="pubmed">31501517</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiedel BJ, et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell. 2018;175:1701&#x2013;1715.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289654</ArticleId><ArticleId IdType="pubmed">30449622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryois J, et al. Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson&#x2019;s disease. Nat. Genet. 2020;52:482&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930801</ArticleId><ArticleId IdType="pubmed">32341526</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:e1004219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Lachmann A, Keenan AB, Ma&#x2019;ayan A. L1000FWD: fireworks visualization of drug-induced transcriptomic signatures. Bioinformatics. 2018;34:2150&#x2013;2152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454499</ArticleId><ArticleId IdType="pubmed">29420694</ArticleId></ArticleIdList></Reference><Reference><Citation>Auton A, et al. A global reference for human genetic variation. Nature. 2015;526:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell S, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007;81:559&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1950838</ArticleId><ArticleId IdType="pubmed">17701901</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander DH, Lange K. Enhancements to the ADMIXTURE algorithm for individual ancestry estimation. BMC Bioinforma. 2011;12:246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146885</ArticleId><ArticleId IdType="pubmed">21682921</ArticleId></ArticleIdList></Reference><Reference><Citation>Marees AT, et al. A tutorial on conducting genome-wide association studies: quality control and statistical analysis. Int J. Methods Psychiatr. Res. 2018;27:e1608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6001694</ArticleId><ArticleId IdType="pubmed">29484742</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Goddard ME, Wray NR, Visscher PM. A better coefficient of determination for genetic profile analysis. Genet Epidemiol. 2012;36:214&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">22714935</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, et al. Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am. J. Hum. Genet. 2012;91:778&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3487133</ArticleId><ArticleId IdType="pubmed">23084292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, et al. HIBAG-HLA genotype imputation with attribute bagging. Pharmacogenomics J. 2014;14:192&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772955</ArticleId><ArticleId IdType="pubmed">23712092</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F, et al. The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012. Ann. Rheum. Dis. 2016;75:136&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4717400</ArticleId><ArticleId IdType="pubmed">25265938</ArticleId></ArticleIdList></Reference><Reference><Citation>Juli&#xe0; A, et al. Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus. Arthritis Res Ther. 2018;20:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977506</ArticleId><ArticleId IdType="pubmed">29848360</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JZ, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 2015;47:979&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4881818</ArticleId><ArticleId IdType="pubmed">26192919</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lange KM, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat. Genet. 2017;49:256&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5289481</ArticleId><ArticleId IdType="pubmed">28067908</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois PC, et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 2010;42:295&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2847618</ArticleId><ArticleId IdType="pubmed">20190752</ArticleId></ArticleIdList></Reference><Reference><Citation>Glanville KP, Coleman JRI, O&#x2019;Reilly PF, Galloway J, Lewis CM. Investigating Pleiotropy Between Depression and Autoimmune Diseases Using the UK Biobank. Biol. Psychiatry Glob. Open Sci. 2021;1:48&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262258</ArticleId><ArticleId IdType="pubmed">34278373</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawcer S, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182531</ArticleId><ArticleId IdType="pubmed">21833088</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecham AH, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 2013;45:1353&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3832895</ArticleId><ArticleId IdType="pubmed">24076602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervais O, et al. Regional heritability mapping identifies several novel loci (STAT4, ULK4, and KCNH5) for primary biliary cholangitis in the Japanese population. Eur. J. Hum. Genet. 2021;29:1282&#x2013;1291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385030</ArticleId><ArticleId IdType="pubmed">33833419</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordell HJ, et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat. Commun. 2015;6:8019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4580981</ArticleId><ArticleId IdType="pubmed">26394269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha E, Bae SC, Kim K. Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci. Ann. Rheum. Dis. 2021;80:558&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053349</ArticleId><ArticleId IdType="pubmed">33310728</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KE, et al. Genome-wide association analysis reveals genetic heterogeneity of sj&#xf6;gren&#x2019;s syndrome according to ancestry. Arthritis Rheumatol. 2017;69:1294&#x2013;1305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5449251</ArticleId><ArticleId IdType="pubmed">28076899</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Isac E, et al. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat. Commun. 2019;10:4955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6823490</ArticleId><ArticleId IdType="pubmed">31672989</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiou J, et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature. 2021;594:398&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">34012112</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, et al. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat. Genet. 2016;48:1418&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120758</ArticleId><ArticleId IdType="pubmed">27723757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>